GLP-1 Receptor Agonist Prescription Patterns in the <i>All of Us</i> Research Program
<i>All of Us</i> CDRv8 is a valuable resource for research on GLP-1RAs across a large, heterogeneous cohort of participants. The variety and availability of data offer many possibilities for future observational, real-world research to address unanswered questions about GLP-1RA use and replicate recent findings generated from other datasets.
Authors
- Josephine M. Egan (ORCID: https://orcid.org/0000-0002-8945-0053)
- Jennifer C. Z. Adjemian
- Tamara R. Litwin (ORCID: https://orcid.org/0000-0003-2130-6263)
- Lorenzo Leggio (ORCID: https://orcid.org/0000-0001-7284-8754)
- Angela Gasdaska (ORCID: https://orcid.org/0009-0002-2038-2272)
- Melissa L McPheeters (ORCID: https://orcid.org/0000-0002-4423-797X)
- Mehdi Farokhnia (ORCID: https://orcid.org/0000-0003-0902-4212)
- Ariba Huda
- Edward Preble
- Benjamin Dylan Tyndall
- Chandan Sastry
- Laura Marcial
- M Daniel Brannock
Institutions
- National Institutes of Health (US)
- RTI International (US)
Publication Details
- Journal
- medRxiv
- Published
- 2026-01-15
- DOI
- https://doi.org/10.64898/2026.01.13.26344022
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- U.S. Department of Health and Human Services
- RTI International
- National Institutes of Health